Screener
CNS Pharmaceuticals CNSP Q1 2026 Annual earnings
Reported May 14, 2026 · After market close
EPS-$7.30Miss by $1.93
EPS estimate-$5.37
Next report
Nov 18, 2026 (in 2 months)EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did CNS Pharmaceuticals report Q1 2026 earnings?
- CNS Pharmaceuticals (CNSP) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were CNS Pharmaceuticals's Q1 2026 revenue and EPS?
- CNS Pharmaceuticals reported eps of $-7.30 for Q1 2026.
- Did CNS Pharmaceuticals beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-5.37 by $1.93.
- Where can I find CNS Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001683168-26-002550) directly on SEC EDGAR. The filing index links above go to sec.gov.
